Member Info for Crocqman

Magsy,
You seem determined to twist other people's comments negatively to suit your own opinion.
I was supporting the good comments made by another poster and used one specific example (SA) to clarify a particular point.

You repeatedly state that there have competed no sales, and that this is supposedly a factual statement.
Perhaps you should read the 30/09 RNS again:
"Under the approval, the Kit can now be distributed and sold within South Africa. Genedrive products are supplied in the country, and more broadly within Africa, via the Sysmex EMEA organisation.
Since the original evaluation, genedrive has expanded the number of PCR platforms and RNA isolation kit providers which are validated for the Company's Kit. This is important for markets such as South Africa where high testing volumes are supported by the prevalence of automated/robotic RNA extraction instruments, and the variety of testing platforms is diverse owing to a split between public and private testing facilities.
David Budd, Chief Executive Officer of genedrive plc, said "This is an important milestone in the commercialisation of our COVID-19 Kit in the region. South Africa is a key territory for our distributors and this approval will now provide an acceleration of commercial sales activity in the area."

An acceleration of commercial sales activity suggests there has alrady been sales to me (otherwise he would have said 'commencement of commercial sales').
As already stated, the trading update will clarify the situation with regards to SA (specifically), so maybe wait on that?

I feel it is not worth commenting further to any of your replies, as your posts are intentionally disruptive.

Good post, Dodge.
When people acknowledge something can be only black or white, it is clear their reasons for doing so.
Signing a new supply contract would be newsworthy and require an RNS.
We have already been informed by RNS that SA approval has been given and that kit can be distributed and sold in SA. Any sales here would be updated in a trading statement, not RNS'd on a weekly/monthly basis.
Saying there has been no sales to date, is a false statement (imo)

It's funny (and sad to see) how the main 'hard core' ukog supporters are now ony 'baiting trolls' rather than discussing actual goings on with factual statements to support their eternal positivity.
Tymers admitted to trolling the trolls and TH2 has done so before too.
Seeing as the main 'trolls' here are providing evidence to back up their statements, whilst the hardcore supporters seem to be making vague (and half-hearted) statements on possibilities to promote this share, it has been clear for some time who is better researched.
There are some good, positive posters here, but the more knowledgeable ones seem to be those that are continually called trolls for posting factual statements rather than supposition.

TH2 has been topping up regularly for well over a year now, just like Tymers. I wonder if TH2 has also been trading ukog to get his average down even further without ever mentioning his Sells just like Tymers was caught out doing?

I was commenting on the point of looking to gain the authority to issue new shares as being a standard bod action.
I was not referring to the calling of a GM outwith the AGM as being a standard action. Unusual, yes, but not uncommon to do so either.
Different viewpoints. The reasons behind this will be known in due course. An IQ could be raised for clarity ahead of the meeting, or after if not satisfactorily discussed by the bod at that time.
In or out on this issue will be a personal choice for shareholders, or potential investors, just like any other aspect.
Good uck whatever anyone decides

HITS,
We know the board are looking at opportunities. Perhaps, the potential success at SFB will accelerate plans for similar opportunities to grow the company quickly, perhaps even a takeover or JV with a larger entity?
All conjrcture, of course.
Much for the many to debate/dissect

butd,
I don't beleive that they have telegraphed that they need more money.
As HITS stated, just because they may have the ability to issue more shares, it does not automatically mean that they will.
Even FTSE 100 stocks willl have the ability to issue more shares in place, it's a contingency in case of an opportunity, a strengthening of their hand rather than a 'given', and allows a company to be more pro-active/flexible towards any potential future opportunity, rather than being caught out.

Imagine if they have to call an EGM just to vote on the issuance of new shares if (IF) they are needed, and what that would do to any possible placing. Now, that would be telegraphing a need for cash and would be detrimental to shareholders, and would not be prudent management by the bod. This just seems to be a standard action of a bod (imo).

The Brockham acquisition on the other hand is an odd one

Mirasol,
You may be right on covenants and restrictions with regard to any lending, we will hae to see the terms of any deal (if full details are given on any agreed arrangement).
Given ther choice though, is this not a preferable source of funding than continually placing?
With the CPR and the off-take agreement, a different avenue of financing future works has potentially been openend which is arguably less detrimental to the continual dilution of shareholderrs through (often heavily) discounted placings.
Surely that is the aim of AIM companies to help them grow, this funding will allow the company to progress to a cash generation stage, which in turn, hopefully, we will lead them to becoming a profitable business

Apologies RB1,
I have had yellow filtered for a while too, and I agree, it is annoying seeing other posters keep replying. I made a cheap shot post last night on the basis of the SP rise and silence from him/her, so I will cease doing this myself (pot, kettle), and concentrate on the good research posted from those with balanced views.
Good weekend all

Some fair points there, although I disagree with the last couple of points about additional shares in issue (due to funding being arranged), and SP once SF is producing.

Have been here a long time too. I invested on the back of the 7 day Balcombe EWT in October 2018, getting in at sub-8p just before the rapid rise to 14p. I took some profits at that level (despite RealAnalsyt's daily ramping posts telling posters they were mad and crazy for selling at these bargain prices and 30p plus was expected 'next week').
I made the mistake of adding again at 9p as the SP dropped back, but held tight when the Brockham RNS landed in June 2019, taking a 'wait and see' approach re: the SF acquisition and the new bod's plan.
At one point, I was 95% down and set myself a target of getting out by the end of this year with only a 50% loss.
As SF news has landed though, my confidence here has returned, and I have added a few times in recent months. My new target is a modest 2p on SF production, which will see me exiting here in profit.
Hopeful that this can be achieved, being at the lower end of expectations from the company figures, although I recognise I will most likely have to wait until Q1 next year for production to commence. I do see a re-rate of sorts before year end though with newsflow expected.
Any additional news (positive) on any other assets over the next 3-4 months will be a bonus, for me.

I agree that SF is make or break time. The markets, for sure, will not tolerate failure with SF, but do seem (imo) cautious of a positive result, given the CPR, Off-take agreement and potential funfing arrangements, of which news is expected soon.
Good luck with your investment, whatever you decide to do here. I will be holding for SF connection

Not saying there's strength.
Just counteracting the blatant lie that the SP is 'tanking daily' which only gets posted every day on a 'red day', but is ignored on a 'blue day' which highlights the blatant disruptive and false nature of the clearly agenda-driven posts.
Fact. More blue days then red in October
Fact. The 3 month chart is generally down (circa 50%)
Fact: The 1 year chart is very good (up over 400%)
We cam all see that the SP is not where genuine investors would like, and that the comms could be a lot better, but there ARE positives (as well as negatives), which any balanced poster would acknowledge.
Selective, and false use of stats to skew opinion says more about the poster than the company

What, no post from yellow today telling everyone the SP is 'diving daily'?
Maybe because it is a blue day, much like the majority of the past 2 weeks of trading days, as per the chart/SP evidence?
Funny that.
Good weekend all

I would say that a so-called 'good' RNS day with the confirmed planning review date that results in less than 100 posts all day, and a SP drop, says everything about the current sentiment here.
The addition of the Holmwood news as a footnote rather than a separate announcement says a lot about management too.
Trying to bury bad news?
Good weekend all

Mirasol,
Disagree that a lot of rampers saw Holmwood as part of a long list of potential positive news flow.
Under the old regime, maybe, or the usual few from that end of the spectrum that all boards get, but not (imo) the majoroty of the posters here of late who are looking mainly at SF (plus the possibility of Balcombe).
All of the other assets are more frequently used by the deramping groups as 'proof' that Angus should be avoided.

This news imo is progress for Angus in their new strategy.

Their last mention of Holmwood was in a response to an IQ back on June where they stated: "The Company has not been informed by the Operator of any immediate spending plans of note and there a consequently nothing beyond minimal expenditures in our budget and forecasts for this prospect".

All other IQ's regarding Angus relate to SF, Balcombe, or general Q's re: Brockham and Lidsey

Agree that this tidies up the portfolio of assets and is in line with new company strategy.
The market does not seem to like this update, however, which seems odd to me given the relative low importance in the grand scheme of things here.
gla

But what were the relative MCAP's at the various SP lows over the same time period?
Don't have the exact figures, but the SP high of 11p in 2017 (for arguments sake) would be the equivalent of something around 4p (or perhaps even less now) with the current shares in issue.
Agree that the current position is pretty unpalateable though (other than new investors taking a punt), and that the company's fortunes have been on a distinct downward trend for the best part of a year

To be fair brent, someone seems to ask this on a daily basis, as well as get multiple replies along with a link to the SCC website.
Pushed back until November, as far as we know (although that is subject to change)

CynderLad,
Posters on here have been calling for updates and meaningfuly communication from SS for years.
I have been invested here for almost 3 years now, and it was a common theme when I first started posting.
Regular comms from SS when things are looking good, but it has been near silence for much of the past 2 years, certainly (imo) since the original EWT back in June/July 2018 and the run up to, and after, the 'commercially viable' news in October that year, the last time there was a real buzz here.
I keep mentioning it, but since the Jan 2019 Drilling campaign RNS, the news here has been limited at best.
We were told 720 to 1,080 bopd from the original horizontal well, and to expect 2,000 bopd plus from the additional wells due in 2020, and that was not even half of the works expected to take place during 2019/20.
Now, it seems all about Turkey, originally advised to start in late 2020, but now, already mentioned as being 2021.
And still the diehards wonder why the LTH's are disheartened

Some positive news, at least, although as typical with ukog who originally notified us all that drilling was expected by year end, it is already only due to commence in Q1.
Small SP rise today?
gla

No idea.
If I read the RNS's correctly, it looks like Vanguard bought at over the official bid price, Millenium increased their long exposure and Blackrock reduced a short position. All released from 3pm onwards.
I may be reading these incorrectly though.
After hours, Schroders confirmed selling down to under 5%.
Could be connected to the SP closing up, not aware of anything external.
The SP did look to be slowly dropping down to the offer price over the past few days, so good to see a halt in that whatever the reason

Thanks both.
The CPR does mention a discount - I think I read 1.8% (without referencing back).
Agree that it is unlikkely to be straightforward to keep a track of likely income from production anyway, but would hope to see output figures released regularly (jumping the gun a bit here, I know).
Again, from memory, I believe the bod estimated SF to be worth around 4.4p based on the higher of the CPR figures. Would expect a downward revision here too though once the funding arrangements have been agreed.
Will stick with my conservative target of 2p plus on 1st delivery (in Q1) for now and hope to be pleasantly surprised.
gla